Stifel Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-27,134
Closed -$4.98M 3478
2021
Q2
$4.98M Sell
27,134
-8,224
-23% -$1.51M 0.01% 1028
2021
Q1
$5.41M Sell
35,358
-90,933
-72% -$13.9M 0.01% 915
2020
Q4
$19.7M Buy
126,291
+9,382
+8% +$1.47M 0.04% 397
2020
Q3
$13.4M Buy
116,909
+5,420
+5% +$620K 0.03% 451
2020
Q2
$12.5M Sell
111,489
-756
-0.7% -$84.9K 0.03% 439
2020
Q1
$10.3M Sell
112,245
-3,439
-3% -$316K 0.03% 440
2019
Q4
$12.6M Buy
115,684
+5,038
+5% +$549K 0.03% 513
2019
Q3
$10.9M Buy
110,646
+11,571
+12% +$1.14M 0.03% 515
2019
Q2
$12.9M Buy
99,075
+17,997
+22% +$2.35M 0.03% 475
2019
Q1
$10.9M Buy
81,078
+13,263
+20% +$1.78M 0.03% 506
2018
Q4
$6.68M Buy
67,815
+520
+0.8% +$51.2K 0.02% 635
2018
Q3
$9.34M Buy
67,295
+5,763
+9% +$800K 0.03% 570
2018
Q2
$7.57M Buy
61,532
+7,109
+13% +$874K 0.02% 632
2018
Q1
$6.07M Buy
54,423
+2,915
+6% +$325K 0.02% 710
2017
Q4
$6.18M Buy
51,508
+2,131
+4% +$256K 0.02% 690
2017
Q3
$6.93M Buy
49,377
+4,518
+10% +$634K 0.02% 624
2017
Q2
$5.45M Sell
44,859
-5,696
-11% -$692K 0.02% 683
2017
Q1
$6.13M Sell
50,555
-38,073
-43% -$4.62M 0.02% 621
2016
Q4
$10.8M Sell
88,628
-113,113
-56% -$13.8M 0.05% 389
2016
Q3
$24.7M Sell
201,741
-24,355
-11% -$2.98M 0.11% 199
2016
Q2
$26.4M Sell
226,096
-14,100
-6% -$1.65M 0.12% 182
2016
Q1
$33.4M Sell
240,196
-61,965
-21% -$8.63M 0.18% 130
2015
Q4
$57.7M Sell
302,161
-36,532
-11% -$6.97M 0.3% 83
2015
Q3
$53M Buy
338,693
+94,419
+39% +$14.8M 0.3% 84
2015
Q2
$44.2M Buy
244,274
+5,889
+2% +$1.07M 0.23% 116
2015
Q1
$41.3M Buy
238,385
+24,366
+11% +$4.22M 0.23% 115
2014
Q4
$39.6M Buy
214,019
+210,198
+5,501% +$38.9M 0.22% 113
2014
Q3
$633K Sell
3,821
-505
-12% -$83.7K 0.01% 1384
2014
Q2
$676K Buy
4,326
+181
+4% +$28.3K 0.01% 1313
2014
Q1
$631K Buy
+4,145
New +$631K 0.01% 1307